pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

$MESOMESOBLAST LTD

$MESO17.43+1.75%
Melbourne, Victoria, AUupdated 1h ago

Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004.

Website ↗SEC EDGAR ↗Yahoo Finance ↗
community read0 votes
pipeline
3
marketed
0
phase 3
3
catalysts ytd
1
approvals ytd
0
recalls ytd
0

Pipeline(3)

pipeline depth3 products
Phase 3: 3
3Phase 3
Phase 3
MPC-06ID
Chronic Low Back Pain (CLBP)
Phase 3
remestemcel-L
Crohn's Disease (Regional Enteritis)
Phase 3
rexlemestrocel-L
Hypoplastic Left Heart Syndrome

📅 Upcoming

Aug 27, 2026
earnings
$MESO17.43+1.75%
in 6d
MESOBLAST LTD earnings
MESOBLAST LTD
→

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Insider activity

source: SEC Form 4

open-market buys + sells

  • Apr 10, 26BUYGeorge Gregory· 2,324,072 sh @ $1.48$3.44M↗
  • Apr 10, 26BUYGeorge Gregory· 2,324,072 sh @ $1.48$3.44M↗
  • Apr 9, 26BUYGeorge Gregory· 500,000 sh @ $14.39$7.20M↗
  • Apr 9, 26BUYGeorge Gregory· 500,000 sh @ $14.39$7.20M↗
  • Apr 9, 26BUYGeorge Gregory· 886,890 sh @ $1.43$1.27M↗
  • Apr 9, 26BUYGeorge Gregory· 886,890 sh @ $1.43$1.27M↗
  • Apr 9, 26BUYGeorge Gregory· 500,000 sh @ $1.44$720K↗
  • Apr 9, 26BUYGeorge Gregory· 20,000 sh @ $14.30$286K↗
  • Apr 9, 26BUYGeorge Gregory· 105,000 sh @ $1.46$153K↗
  • Apr 9, 26BUYGeorge Gregory· 10,000 sh @ $14.40$144K↗
  • Apr 9, 26BUYGeorge Gregory· 10,000 sh @ $14.30$143K↗
  • Apr 9, 26BUYGeorge Gregory· 10,000 sh @ $14.30$143K↗
  • Apr 9, 26BUYGeorge Gregory· 10,000 sh @ $14.30$143K↗
  • Apr 9, 26BUYGeorge Gregory· 10,000 sh @ $14.25$143K↗
  • Apr 9, 26BUYGeorge Gregory· 10,000 sh @ $14.10$141K↗
  • Apr 9, 26BUYGeorge Gregory· 5,240 sh @ $14.25$75K↗
  • Apr 9, 26BUYGeorge Gregory· 5,000 sh @ $14.30$72K↗
  • Apr 9, 26BUYGeorge Gregory· 4,760 sh @ $14.40$69K↗
  • Apr 9, 26BUYGeorge Gregory· 20,000 sh @ $1.43$29K↗
  • Apr 9, 26BUYGeorge Gregory· 10,000 sh @ $1.44$14K↗
🐶 Hiring Signal
next earnings Aug 27, 2026
No open roles indexed yet — view MESOBLAST LTD jobs →

News

no news has mentioned this company yet
identifiers
ticker
$MESO
SEC CIK
0001345099
country
AU
source
sec_tickers
top tags
Cardiology1Duchenne Muscular Dystrophy1Immunology1
mentioned in
0news items
entity-linker matched
Data sources
SEC EDGAR · openFDA
last refreshed 9m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?